SPECTRUM PHARMACEUTICALS INC (SPPI) Fundamental Analysis & Valuation

NASDAQ:SPPI • US84763A1088

1.03 USD
0 (0%)
At close: Jul 31, 2023
1.04 USD
+0.01 (+0.97%)
After Hours: 7/31/2023, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SPPI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

SPPI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 519 industry peers in the Biotechnology industry. Both the profitability and financial health of SPPI have multiple concerns. SPPI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. SPPI Profitability Analysis

1.1 Basic Checks

  • SPPI had negative earnings in the past year.
  • In the past year SPPI has reported a negative cash flow from operations.
SPPI Yearly Net Income VS EBIT VS OCF VS FCFSPPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

  • The profitability ratios for SPPI are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPPI Yearly ROA, ROE, ROICSPPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

  • SPPI's Gross Margin of 32.34% is fine compared to the rest of the industry. SPPI outperforms 75.42% of its industry peers.
  • SPPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPPI Yearly Profit, Operating, Gross MarginsSPPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SPPI Health Analysis

2.1 Basic Checks

  • SPPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SPPI has more shares outstanding
  • Compared to 1 year ago, SPPI has a worse debt to assets ratio.
SPPI Yearly Shares OutstandingSPPI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
SPPI Yearly Total Debt VS Total AssetsSPPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -14.02, we must say that SPPI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -14.02, SPPI is doing worse than 86.78% of the companies in the same industry.
  • A Debt/Equity ratio of 1.08 is on the high side and indicates that SPPI has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.08, SPPI is doing worse than 83.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Altman-Z -14.02
ROIC/WACCN/A
WACC8.97%
SPPI Yearly LT Debt VS Equity VS FCFSPPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

  • SPPI has a Current Ratio of 2.71. This indicates that SPPI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.71, SPPI is doing worse than 76.44% of the companies in the same industry.
  • SPPI has a Quick Ratio of 2.38. This indicates that SPPI is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.38, SPPI is not doing good in the industry: 77.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 2.38
SPPI Yearly Current Assets VS Current LiabilitesSPPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SPPI Growth Analysis

3.1 Past

  • SPPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.62%, which is quite impressive.
EPS 1Y (TTM)58.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • SPPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.88% yearly.
  • Based on estimates for the next years, SPPI will show a very strong growth in Revenue. The Revenue will grow by 98.74% on average per year.
EPS Next Y88.67%
EPS Next 2Y51.91%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue Next Year722.64%
Revenue Next 2Y275.85%
Revenue Next 3Y179.1%
Revenue Next 5Y98.74%

3.3 Evolution

SPPI Yearly Revenue VS EstimatesSPPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
SPPI Yearly EPS VS EstimatesSPPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. SPPI Valuation Analysis

4.1 Price/Earnings Ratio

  • SPPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 7.97 indicates a rather cheap valuation of SPPI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SPPI indicates a rather cheap valuation: SPPI is cheaper than 98.98% of the companies listed in the same industry.
  • SPPI is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.97
SPPI Price Earnings VS Forward Price EarningsSPPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPPI Per share dataSPPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • SPPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SPPI's earnings are expected to grow with 39.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.91%
EPS Next 3Y39.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SPPI Dividend Analysis

5.1 Amount

  • SPPI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SPPI Fundamentals: All Metrics, Ratios and Statistics

SPECTRUM PHARMACEUTICALS INC

NASDAQ:SPPI (7/31/2023, 8:00:02 PM)

After market: 1.04 +0.01 (+0.97%)

1.03

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-10
Earnings (Next)11-08
Inst Owners0.06%
Inst Owner Change0%
Ins Owners1.22%
Ins Owner Change0%
Market Cap211.40M
Revenue(TTM)25.73M
Net Income(TTM)-64.97M
Analysts50
Price Target1.29 (25.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.99%
Min EPS beat(2)54.61%
Max EPS beat(2)69.36%
EPS beat(4)3
Avg EPS beat(4)34.68%
Min EPS beat(4)-5.49%
Max EPS beat(4)69.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)25.37%
Min Revenue beat(2)11.17%
Max Revenue beat(2)39.57%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-34.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.45%
EPS NY rev (1m)78.12%
EPS NY rev (3m)78.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)40.01%
Revenue NY rev (1m)47.89%
Revenue NY rev (3m)47.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.97
P/S 8.22
P/FCF N/A
P/OCF N/A
P/B 7.89
P/tB 7.89
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.13
Fwd EY12.54%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.13
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.34%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.46%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.71
Quick Ratio 2.38
Altman-Z -14.02
F-Score3
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)772.71%
Cap/Depr(5y)966.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y88.67%
EPS Next 2Y51.91%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year722.64%
Revenue Next 2Y275.85%
Revenue Next 3Y179.1%
Revenue Next 5Y98.74%
EBIT growth 1Y50.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.22%
OCF growth 3YN/A
OCF growth 5YN/A

SPECTRUM PHARMACEUTICALS INC / SPPI FAQ

What is the ChartMill fundamental rating of SPECTRUM PHARMACEUTICALS INC (SPPI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SPPI.


What is the valuation status for SPPI stock?

ChartMill assigns a valuation rating of 4 / 10 to SPECTRUM PHARMACEUTICALS INC (SPPI). This can be considered as Fairly Valued.


What is the profitability of SPPI stock?

SPECTRUM PHARMACEUTICALS INC (SPPI) has a profitability rating of 1 / 10.


Can you provide the dividend sustainability for SPPI stock?

The dividend rating of SPECTRUM PHARMACEUTICALS INC (SPPI) is 0 / 10 and the dividend payout ratio is 0%.